TENAX THERAPEUTICS INC (TENX)       1.75  -0.46 (-20.81%)

1.75  -0.46 (-20.81%)

US88032L5066 - Common Stock - After market: 1.8 +0.05 (+2.86%)

TENAX THERAPEUTICS INC1.75

NASDAQ:TENX (2/3/2023, 7:10:48 PM)-0.46 (-20.81%)

After market: 1.8 +0.05 (+2.86%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-10 2022-11-10/amc Earnings (Next) 03-27 2023-03-27/amc
Ins Owners 203.87% Inst Owners 151.22%
Market Cap 4.01M Shares 2.29M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 82.86
IPO 10-28 1993-10-28

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

TENX Daily chart

Company Profile

Tenax Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Chapel Hill, North Carolina and currently employs 8 full-time employees. Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need. The firm's products include TNX-103 (oral levosimendan) and TNX-201 (oral enteric coated imatinib). The firm's lead product, Levosimendan, is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. TNX-201 is for the treatment of pulmonary arterial hypertension (PAH), which is a fatal orphan disease. The firm has completed Phase II clinical trial of levosimendan in North America for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF).

Company Info

TENAX THERAPEUTICS INC

101 Glen Lennox Drive, Suite 300

Chapel Hill NORTH CAROLINA 27560

P: 19198552100.0

CEO: Anthony DiTonno

Employees: 8

Website: http://www.tenaxthera.com/

TENX News

News Imagea day ago - ChartmillTop movers in Friday's session

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.

News Imagea day ago - ChartmillThese stocks are moving in today's session

Let's have a look at the top gainers and losers in the middle of the day of today's session.

News Image2 days ago - ChartmillThese stocks are gapping in today's session

Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.

News Image2 days ago - ChartmillWhat's going on in today's pre-market session

Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.

News Image2 days ago - Seeking AlphaTenax Therapeutics stock dips after pricing $15.6M securities offering (NASDAQ:TENX)

Tenax Therapeutics (TENX) shares fell 14% after the pharmaceutical company priced its $15.6M securities offering.The offering comrpises 8.66M shares of common stock (or pre-funded...

News Image2 days ago - Tenax TherapeuticsTenax Therapeutics Announces Pricing of Approximately $15.6 Million Public Offering

CHAPEL HILL, N.C., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying,...

TENX Twits

Here you can normally see the latest stock twits on TENX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example